KLOW is not approved by the FDA, the EMA, or any comparable regulator for tissue repair, injury recovery, inflammation, or any other condition
Results are theoretically permanent because destroyed fat cells do not regenerate
The key selling point so far, based on phase 1 data, could be that it requires less frequent administrationit could be administered monthly, instead of the weekly Zepboundand may lead to longer maintenance of weight loss after stopping therapy. In addition, Andersen says Amgens offering has showed compelling speed of weight loss
npj Cardiovasc Health
AJR Am J Roentgenol 166(5):10851088
Synthesized using precision solid-phase peptide synthesis and purified to 99% HPLC, Ipamorelin offers excellent molecular stability and reproducibility